A CASE OF CUTANEOUS BULLOUS MASTOCYTOSIS IN A YORKSHIRE TERRIER PUPPY
Rubrics: DERMATOLOGY
Authors:
1.
University of Zagreb
(Clinic for Internal Diseases)
employee
Russian Federation
employee
Russian Federation
2.
University of Zagreb
(Department of Veterinary Pathology)
employee
Russian Federation
employee
Russian Federation
3.
University of Zagreb
(Department of Veterinary Pathology)
employee
Russian Federation
employee
Russian Federation
4.
University of Zagreb
(Clinic for Internal Diseases)
employee
Russian Federation
employee
Russian Federation
Type:
Article
Pages:
from 54
to 56
Status:
Published
Received:
14.04.2023
Accepted:
14.04.2023
Published:
14.04.2023
Subject area:
VAC 4.2.1 Патология животных, морфология, физиология, фармакология и токсикология
GRNTI 68.41 Ветеринария
GRNTI 68.41 Ветеринария
Language:
Russian
Keywords:
cutaneous bullous mastocytosis (CBM), dog, erythroderma, bullae formation, treatment
Abstract (English):
Background: Cutaneous bullous mastocytosis (CBM) is a rare disease characterised by erythroderma, bullae formation on trunk, scalp and extremities which evolve to erosions. Objective: To describe a rare variant of cutaneous mastocytosis and treatment options. Animal: A 7-month-old Yorkshire terrier puppy with erythroderma and bullae formation. Methods: Clinical examination (including haematological, biochemical and radiographic), skin biopsy, histopathological and immunohistochemical evaluation. Conclusion and clinical relevance: The case fulfills the criteria of CBM, representing a rare entity that is reported to be associated with spontaneous regression. However, in severe cases treatment with systemic corticosteroids, H1 and H2 antihistamines, and masitinib can be performed.
Background: Cutaneous bullous mastocytosis (CBM) is a rare disease characterised by erythroderma, bullae formation on trunk, scalp and extremities which evolve to erosions. Objective: To describe a rare variant of cutaneous mastocytosis and treatment options. Animal: A 7-month-old Yorkshire terrier puppy with erythroderma and bullae formation. Methods: Clinical examination (including haematological, biochemical and radiographic), skin biopsy, histopathological and immunohistochemical evaluation. Conclusion and clinical relevance: The case fulfills the criteria of CBM, representing a rare entity that is reported to be associated with spontaneous regression. However, in severe cases treatment with systemic corticosteroids, H1 and H2 antihistamines, and masitinib can be performed.
Keywords:
cutaneous bullous mastocytosis (CBM), dog, erythroderma, bullae formation, treatment
cutaneous bullous mastocytosis (CBM), dog, erythroderma, bullae formation, treatment
1. Spiska net
